Introducing Michael Licata, the Chief Executive Officer at American Vascular Associates. Boasting a distinguished background in healthcare leadership, Michael’s journey to our organization is punctuated by remarkable achievements and an unwavering dedication to success.

In his most recent role as the Chief Strategy Officer at Pinnacle Treatment Centers, Michael showcased strategic acumen and leveraged his extensive healthcare experience to shape the company’s future direction. Prior to this, he served as the Executive Vice President and Chief Development Officer at Healogics Inc., where his leadership played a pivotal role in tripling the company’s wound center footprint.

Before making impactful contributions to private equity-backed healthcare companies, Michael demonstrated his sales and leadership prowess as the North America Vice President of Sales for Nuclear Medicine and Oncology at Philips Medical Systems. Notably, he was the founding general manager who established Philips’ pre-clinical molecular imaging business, highlighting his entrepreneurial spirit.

Commencing his career as a sonar systems engineer, Michael transitioned into healthcare with GE Medical Systems. He quickly emerged as a top performer in the company’s Technical Sales Program. Michael holds a Bachelor of Science in electrical engineering from Clarkson University, complemented by an executive MBA from Stanford University.

Bringing a wealth of experience and a proven track record of success, Michael Licata is a dynamic leader with a passion for growth and innovation. His leadership style positions him as a driving force behind our commitment to delivering exceptional vascular care at American Vascular Associates.